In contrast, about one-third of breast tumors show CP gene amplification, including SCRIB (14.7%), LLGL2 (7%), PRKCI (protein kinase C, iota) (5%), PARD6B (partitioning defective 6 homolog beta) (4.9%), DLG1 (3.92%), and DLG2 (discs large homolog 2) (3.92%) [36]. This evidence concerns the gene PRKCI and breast neoplasm.